Bisphosphonate therapy in the oncology setting

Author： Lipton Allan  

Publisher： Informa Healthcare

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.8, Iss.2, 2003-11, pp. : 469-488

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bisphosphonate Therapy in the Treatment of Multiple Myeloma

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-01 ,pp. : 3028-3036

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of Long-Term Bisphosphonate Therapy for the Management of Osteoporosis

By Lewiecki E. Michael  

Drugs, Vol. 71, Iss. 6, 2011-04 ,pp. : 791-814

Adis International

Access to resources Recommend Favorite

Intermittent Bisphosphonate Therapy in Postmenopausal Osteoporosis: Progress to Date

By Reginster Jean-Yves  

Drugs & Aging, Vol. 24, Iss. 5, 2007-01 ,pp. : 351-359

Adis International

Access to resources Recommend Favorite

Alternative Use of Bisphosphonate Therapy for Rheumatic Disease

By  

Current Pharmaceutical Design, Vol. 16, Iss. 27, 2010-09 ,pp. : 3045-3052

Bentham Science Publishers

Access to resources Recommend Favorite

Photodynamic therapy in oncology

By Kinsella Timothy J   Colussi Valdir C   Oleinick Nancy L   Sibata Claudio H  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 917-927

Informa Healthcare

Access to resources Recommend Favorite